IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.

@article{Soininen2009IgGAC,
  title={IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.},
  author={Anu Soininen and Hanna Nohynek and Marilla Lucero and Kaisa Jousimies and Juanita M Ugpo and Gail M. Williams and Helena M. K{\"a}yhty},
  journal={Vaccine},
  year={2009},
  volume={27 20},
  pages={2680-8}
}
BACKGROUND Pneumococcal pneumonia is a major cause of morbidity and mortality worldwide. Efficacy of pneumococcal conjugate vaccines (PCV) in reducing childhood pneumonia has been estimated in four double-blind, randomized, controlled trials. An investigational 11-valent pneumococcal conjugate vaccine (11PCV) had an efficacy of 22.9% against radiologically… CONTINUE READING